Shri Ahimsa Naturals Ipo
Objects of the Issue
Investment in our Wholly-Owned Subsidiary, Shri Ahimsa Healthcare Private Limited (SAHPL) for setting up a manufacturing unit at Sawarda, Jaipur, Rajasthan
General Corporate Purposes
Shri Ahimsa Naturals IPO Review
IPO Watch – May Apply
Canara Bank –
DRChoksey FinServ –
Emkay Global –
Hem Securities –
IDBI Capital –
Marwadi Shares –
Nirmal Bang –
SBICAP Securities –
Sharekhan –
SMC Global –
Sushil Finance –
Swastika Investmart –
Ventura Securities –
Geojit –
Reliance Securities –
Capital Market –
BP Wealth –
ICICIdirect –
Choice Broking –
IPO Lead Managers aka Merchant Bankers
Srujan Alpha Capital Advisors Llp
Application | Lot Size | Shares | Amount |
Retail Minimum | 1 | 1200 | ₹1,42,800 |
Retail Maximum | 1 | 1200 | ₹1,42,800 |
S-HNI Minimum | 2 | 2400 | ₹2,85,600 |
IPO Open Date: | March 25, 2025 |
IPO Close Date: | March 27, 2025 |
Basis of Allotment: | March 28, 2025 |
Refunds: | April 1, 2025 |
Credit to Demat Account: | April 1, 2025 |
IPO Listing Date: | April 2, 2025 |
Period Ended | Revenue | Expense | Profit After Tax | Assets |
2022 | ₹58.94 | ₹43.18 | ₹11.02 | ₹40.34 |
2023 | ₹106.14 | ₹55.34 | ₹38.21 | ₹74.13 |
2024 | ₹78.70 | ₹53.39 | ₹18.67 | ₹103.15 |
September 2024 | ₹41.37 | ₹28.20 | ₹9.74 | ₹111.39 |
KPI | Values |
ROE: | 22.25% |
ROCE: | 25.69% |
EBITDA Margin: | 35.12% |
PAT Margin: | 23.91% |
Debt to equity ratio: | 0.07 |
Earning Per Share (EPS): | ₹10.19 (Basic) |
Price/Earning P/E Ratio: | N/A |
Return on Net Worth (RoNW): | 22.25% |
Net Asset Value (NAV): | ₹45.79 |
Company | EPS | PE Ratio | RoNW % | NAV | Income |
NA | NA | NA | NA | NA | – Cr. |
NA | NA | NA | NA | NA | – Cr. |
IPO Open Date: | March 25, 2025 |
IPO Close Date: | March 27, 2025 |
Face Value: | ₹10 Per Equity Share |
IPO Price Band: | ₹113 to ₹119 Per Share |
Issue Size: | Approx ₹73.81 Crores |
Fresh Issue: | Approx ₹50.02 Crores |
Offer for Sale: | Approx 19,99,200 Equity Shares |
Issue Type: | Book Built Issue |
IPO Listing: | NSE SME |
Retail Quota: | Not more than 35% |
QIB Quota: | Not more than 50% |
NII Quota: | Not more than 15% |
DRHP Draft Prospectus: | Click Here |
RHP Draft Prospectus: | Click Here |
Anchor Investors List: | Click Here |